Prevalence: Mean values for prevalence of hypertension in 18 selected populations, varied between 15.7% (BP у 95 mm Hg) and 27.7% (BP у 90 mm Hg). In three Mall surveys in Salvador (n = 5093 volunteers), prevalence mean value was 33.7% (JNC VI criteria), being influenced by age (5.5 to 17.8% and 41.0 to 54.9% for the 25-34 and 55-59 year old age groups, respectively) and socioeconomic class (24.7 and 39.6% for the highest and lowest social class, respectively, OR = 0.50 (0.26-0.95, P = 0.023). The national prevalence by the Ministry of Health is 20%. Mortality and morbidity: Mortality as a consequence of morbidity has increased, with stroke being a leading cause of death (11.3% of total deaths, 10.1% of all deaths in the 20-59 year-old age group, and 33.9% of cardiovascular deaths in Brazilian Capitals, 1994). Cardiovascular risk factors: At comparable age groups, prevalence of other major cardiovascular risk factors are: smoking ෂ27%, total cholesterol у200 mg/dl ෂ32.5%, glucose intolerance ෂ8.0%, diabetes ෂ7.5%, BMI 25-29 ෂ29.1%, BMI у 30ෂ9.6%, and physical inactivity ෂ92%. Awareness, treatment, and control: Data are very scarce. In the total Mall population (n = 4613) in Salvador, a high blood pressure was present in 24.4% of those who either denied hypertension or ignored blood
Introduction
In Brazil, hypertension is a very high prevalent condition, with a tendency to increase as population's longevity increases, and is a major risk factor for cerebrovascular disease, ischaemic heart disease, and cardiac and renal failure.
Prevalence and incidence
Prevalence obtained from representative random populations does not exist. There has never been a family-based epidemiological study including representative samples of the Brazilian population within each one of the five geographic regions (north, northeast, midwest, southeast, and south). Data available came from selected populations, pressure. Of those who reported to be hypertensives, only 34.5% had their blood pressure Ͻ140/90 mm Hg. In a national inquiry including 2519 physicians, 88% would start treatment with drug monotherapy, diuretics (53%), and angiotensin-converting enzyme inhibitor (ACEI) (24%). If blood pressure control is not achieved, 55% will combine with another drug (diuretic + ACEI (46%) or + beta-blocker (24%)), and 33% will increase the dosage. Nonpharmacological treatment would be prescribed for every patient by 17% of the physicians, while 62% would prescribe it for 25% of their patients. Adhesion is better for pharmacological (60%) than for nonpharmacological treatment (8%). mainly from southeastern Brazil. Lessa 1 selected 18 studies considered the best from the methodological standpoint: 11 (61.1%) from the southeast, and 54.5% from São Paulo, the most powerful economy in Brazil. In these 18 studies, samples varied from 352 to 5500 individuals, with minimal age ranging from Ͼ15 to Ͼ29 years and maximal age from 59 to 86 years. Prevalence varied according to the diastolic pressure cut-off values: if у95 mm Hg it ranged from 7.8 to 28.3%, mean of 15.7%, and if у90 mm Hg it ranged from 21.0 to 29.4%, mean of 27.7%; if gender was considered, these mean percentages were 16 and 32.7% for males and 16.5 and 22.8% for females, respectively. By age group, the data from Araraquara (São Paulo, southeast) showed an increase in prevalence from 17.8% in the 25 to 34 year age group to 54.9% in the 55 to 59 year age group. In Porto Alegre (Rio Grande do Sul, south), the increase in prevalence was from 5.5% to 41.0% for the same age groups (OMS criteria). Race showed a slight preponderance of black people, with a 1.5 black/white mean ratio. Regarding education, there was a 3.6 ratio preponderance of illiterates in relation to those with second-and third-degree educational levels. In Salvador, Bahia (northeast), the Bahian League of Hypertension and Atherosclerosis carried out surveys for cardiovascular risk factors, in 1996, 1997 and 1999, at three Malls localized in areas of high income class (A), 2 mixed middle and low income class (B), 3 and low income class people (C). 4 As depicted in Table 1 , prevalence was lower (24.7%) in A people as compared with C people (39.6%), with a similar preponderance of women (OR = 0.50, 95% CI 0.26-0.95, P = 0.023). These surveys were carried out by well trained staff, including physicians, nurses, nutritionists, psychologist and social assistants, and blood pressure measurements were conducted through previous calibrated sphygmomanometers. Individuals were selected as volunteers. These figures are comparable with those from two cities in the state of São Paulo, using the same diagnostic criteria (JNC VI), 37.9% (Araraquara) and 32.7% (Piracicaba). In 1997, the Brazilian Ministry of Health estimates a national prevalence of hypertension of 20% (ෂ20 million people) for the population у20 years of age. 5 The lack of data on incidence is worse than for prevalence. Only one study was performed in a very selected male population, 93% between 20 and 49 years old, followed between 2 and 9 years, within a petrochemical plant in Bahia. The average annual figure was 19.7/1000 individuals per year. 
Morbidity and mortality
Hypertension has declined as a primary cause of death. Mortality coefficient for hypertensive disease has decreased, at least in the most developed cities. In São Paulo, it decreased from 52.1/100 000 inhabitants in 1950, to 14.4/100 000 in 1976. 1 However, during these years, target-organ complications of hypertension such as stroke, myocardial infarction, and renal and cardiac failures are becoming leading causes of incapacity and death.
National data, from 1994, showed cerebrovascular disease as a leading cause of death, responsible for 11.3% of total deaths and 33.9% of cardiovascular deaths, above 9.3% and 28.0%, respectively, because of ischaemic heart disease. 6 In proportion to other causes of death, stroke mortality has increased 4.4 times since 1940 in all five Brazilian geographic regions, except for the south and southeast, where it has decreased since 1981-1985 and 1986-1988, respectively.
1 Stroke mortality in Brazil is very high in the р60 year age group when compared with rates from the post-industrialised world. So, data from 1988 showed stroke as responsible for 10.1% of all deaths in the 20 to 59-year age group, representing 30% of cerebrovascular deaths, far above the 12% in the post-industrialised world. Within this picture, hypertension has been an associated condition in 53.4% of the fatal strokes. 1 There is no data assessing the strengths of hypertension as a risk factor for myocardial infarction and renal and cardiac failure, but anecdotal data and clinical experience point toward a strong role of hypertension as a major risk factor for these conditions, as occurs in the USA.
Cardiovascular risk factors
Risk factors such as tobacco smoking, hypercholesterolaemia, glucose intolerance and type 2 diabetes mellitus, excessive weight and obesity, and physical inactivity are commonly associated with high blood pressure, contributing to increase the risk of cardiovascular complications. In the general population, prevalence of cigarette smoking varies from 24.1 to 30%; total cholesterol у200 mg/dl is 35% for men and 30% for women; total cholesterol у240 mg/dl is 10.7% for males and 6.9% for females; glucose intolerance varies between 4.5 to 12.2%; diabetes between 5.2 to 9.7%; excessive weight (BMI 25-29) is 31.5% for males and 26.6% for females; obesity (BMI у 30) 7.0% for males and 12.2% for females; and physical inactivity is 92%. 5, 7 Variations in these figures must be the influence of social, economic, geographic and methodological factors. In the 1999 Mall data from Salvador, for instance, the prevalence of BMI 25-29 kg/m 2 was 38.1% and у30 kg/m 2 was 17.4%, 1.3 and 1.8 higher, respectively, than the 1996/1997 national figures reported by the Ministry of Health. 3, 5 In those individuals, high blood pressure was significantly associated with a BMI у25 (OR = 2.81, 95% CI, 2.43-3.25). 3 In subgroups of the Mall population, the prevalence of a high risk total cholesterol level (у240 mg/dl) was lower in the highest socioeconomic class (15.7%) as compared with the lowest (29.0%) (OR = 0.47%, 95% CI 0.22-0.98, P = 0.028), Table 2 . A tendency in the same direction was also observed when the prevalence of obesity (BMI у30 kg/m 2 ) was considered (9.0% for A against 17.4% and 15.5% for B and C subgroups, respectively), Table 2 . 
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Awareness, treatment and control of blood pressure
Data is very scarce. As shown in Table 3 , in the total Mall population (n = 4613), at Salvador, 19.6% of the volunteers ignored their blood pressure value, with 30.7% showing a high blood pressure. Among those who denied hypertension (51.2%), a high blood pressure was found in 21.9%. Taking together these two subgroups, 24.4% of these volunteers became aware of the probability of having hypertension and of the need to have further medical assessment. On the other hand, of those who reported to be hypertensive, only 34.5% had blood pressure Ͻ140/90 mm Hg, suggesting that hypertension was not under control in 65.5%.
The way some Brazilian physicians treat hypertension may be inferred from a national inquiry answered by 2519 internists. 8 The results showed that only 17% prescribed nonpharmacological measures for all patients, while 62% would do it only for 25% of their patients. These measures include a low sodium diet (55%), weight control (29%) and exercise (8%). Monotherapy is the preference to start pharmacological treatment (88%) of mild and moderate hypertension, and diuretics (53%) and angiotensin-converting enzyme inhibitors (ACEI) (24%) were the most used drugs. If blood pressure control is not satisfactory, then 55% would combine 
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it with another drug with a different mechanism (diuretic + ACEI (46%) or diuretic + beta-blocker (24%)) and 33% would increase the dosage of the drug being used. Drug choice is primarily a consequence of personal experience with a drug (32%), clinical characteristics of the patient (31%), and drug efficacy (20%). Adhesion to treatment is better for pharmacological (60%) than for nonpharmacological (8%) treatment.
Final remarks and perspectives
Hypertension is a leading health problem and a great challenge for the Brazilian health care system. As occurs throughout the world, a significative proportion of the adult population is still unaware of their blood pressure, and around 25.4% of them have high blood pressure at a casual measurement. The prevalence of excessive weight and obesity are also high and closely associated with an elevated blood pressure. The prevalence of tobacco smoking and hypercholesterolaemia also are of concern as major risk factors for cardiovascular disease, highly prevalent in patients with arterial hypertension. Nonpharmacological treatment should be envisaged as the basis for the treatment of hypertension, and the multi-professional approach is of paramount importance in this regard. The pharmacological approach of a sample of Brazilian physicians is in agreement with international and national recommendations and with the income level of the majority of the Brazilian salaried population. The Government and the Brazilians Societies of Cardiology, Hypertension, and Nephrology recognise hypertension as a first priority public health problem now and for the years to come. Thus, in a joint effort to fight against this strong enemy, several measures are already being executed and others planned in the near future. Merit special mention the three Consensus Document issued by the three societies, the last one in 1998, the celebration of the 
